Allred Capital Management’s Alaunos Therapeutics TCRT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-1,687
| Closed | -$11.8K | – | 177 |
|
|
2024
Q2 | $11.8K | Hold |
1,687
| – | – | ﹤0.01% | 170 |
|
|
2024
Q1 | $30.5K | Hold |
1,687
| – | – | 0.01% | 170 |
|
|
2023
Q4 | $17.9K | Hold |
1,687
| – | – | 0.01% | 166 |
|
|
2023
Q3 | $33.3K | Hold |
1,687
| – | – | 0.02% | 152 |
|
|
2023
Q2 | $129K | Buy |
1,687
+334
| +25% | +$25.5K | 0.06% | 157 |
|
|
2023
Q1 | $128K | Buy |
1,353
+66
| +5% | +$6.24K | 0.07% | 154 |
|
|
2022
Q4 | $125K | Buy |
1,287
+234
| +22% | +$22.8K | 0.07% | 149 |
|
|
2022
Q3 | $271K | Buy |
1,053
+33
| +3% | +$8.49K | 0.17% | 120 |
|
|
2022
Q2 | $189K | Buy |
1,020
+167
| +20% | +$30.9K | 0.12% | 151 |
|
|
2022
Q1 | $83K | Buy |
853
+166
| +24% | +$16.2K | 0.04% | 166 |
|
|
2021
Q4 | $112K | Buy |
687
+334
| +95% | +$54.5K | 0.05% | 181 |
|
|
2021
Q3 | $96K | Buy |
353
+140
| +66% | +$38.1K | 0.05% | 175 |
|
|
2021
Q2 | $84K | Buy |
213
+33
| +18% | +$13K | 0.04% | 181 |
|
|
2021
Q1 | $97.2K | Hold |
180
| – | – | 0.04% | 266 |
|
|
2020
Q4 | $68K | Sell |
180
-15
| -8% | -$5.67K | 0.04% | 170 |
|
|
2020
Q3 | $73K | Buy |
195
+33
| +20% | +$12.4K | 0.04% | 160 |
|
|
2020
Q2 | $79K | Sell |
162
-26
| -14% | -$12.7K | 0.05% | 158 |
|
|
2020
Q1 | $69K | Buy |
188
+28
| +18% | +$10.3K | 0.05% | 133 |
|
|
2019
Q4 | $113K | Buy |
160
+17
| +12% | +$12K | 0.06% | 199 |
|
|
2019
Q3 | $88K | Hold |
143
| – | – | 0.05% | 160 |
|
|
2019
Q2 | $116K | Hold |
143
| – | – | 0.07% | 174 |
|
|
2019
Q1 | $86K | Hold |
143
| – | – | 0.05% | 183 |
|
|
2018
Q4 | $40K | Buy |
+143
| New | +$40K | 0.03% | 171 |
|